Regeneration of Damaged Tissue

a tissue and repair technology, applied in the field of wound healing, can solve the problems of fibrosis and scar formation, other tissues are not capable of regeneration, and re-epithelialization must occur, so as to reduce scar tissue and minimize scar tissue

Inactive Publication Date: 2016-07-07
APTALIS PHARMA
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0038]wherein the re-epithelialization of the wound minim

Problems solved by technology

Other tissues are not capable of regeneration, and may only undergo repair mechanisms leading to fibrosis and scar formation.
However, if the basement membrane is ruined at the wound site, re-epithelialization must occur from the wound margins

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Regeneration of Damaged Tissue
  • Regeneration of Damaged Tissue
  • Regeneration of Damaged Tissue

Examples

Experimental program
Comparison scheme
Effect test

example 1

Dermal Regeneration Full Thickness Surgical Wounds

[0090]The current study assessed the impact of recombinant human tropoelastin (rH TE) on dermal regeneration of full thickness surgical wounds in a pig model following the application of Integra Dermal Template with and without rH TE. Analysis of the regenerated dermis at two weeks revealed that the presence of rH TE in Integra Dermal Template led to an improved wound repair process. The improvement was marked by increased numbers of fibroblast, elevated collagen deposition, increased vascularization of the regenerated dermal tissue, and an increased level of detected elastin fibers in the regenerated dermis. These events were accompanied by increased keratinocyte proliferation resulting in improved epithelialization of the wound due to the presence of rH TE.

[0091]Materials and Methods

[0092]Test Items

[0093]Three products were assessed in the current study:[0094]Control: Integra Dermal Template[0095]Test A: Integra Dermal Template inc...

example 2

Use of Electrospun, Co-Precipitate and Gel Based Formulations

[0123]Pigs were utilized in the current study, each with four, circular, 5 cm diameter, wound sites, two on each side of the animal. For each pig, two wounds from one side were covered with a commercially available skin template product, and two wounds from the other side were treated with either test item A, B or C.[0124]Day 0[0125]Four full thickness excisional circular wounds with 5 cm in diameter were created on the upper backs of each pig as noted in the diagram above.[0126]Each wound was treated with either the control skin template or Test Item A, B or C.[0127]Day 7 (week 1)[0128]Dressing changes for all wounds.[0129]Day 14 (week 2)[0130]4 mm biopsies were taken from each wound site a few mm away from the edge of the wounds as depicted in FIG. 1B.

[0131]Wound Analysis

[0132]Sampling at the wound site was first undertaken two weeks after surgery and treatment. Biopsy of the wound site was conducted as described above. ...

example 3

Assessment of Epithelial Regeneration in a Porcine Needling Skin Model

[0139]Pigs were each treated with up to ten 2 cm×2 cm sites across the dorsum. Each site received one of three treatment methods:[0140]1) Site A: Received puncture wounds using a micro-coring needle approximately every 2 mm apart across the area of skin to be treated. Following the needle treatment a gel containing 1% to 5% w / v tropoelastin protein was applied topically to the treated area and held in place by a Tegaderm dressing to enable the gel to be retained and pass into the puncture sites.[0141]2) Site B: Received puncture wounds using a hypodermic needle with each puncture including the injection of 0.05 to 0.5 ml of a 1 to 5% w / v tropoelastin gel into the upper dermis of the skin tissue. The puncture / injections were applied approximately 2 mm apart across the area of skin to be treated followed by wound dressing.[0142]3) Site C: Received the implantation of 0.5 to 2 ml of a 1 to 5% w / v tropoelastin gel in ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Massaaaaaaaaaa
Densityaaaaaaaaaa
Login to view more

Abstract

A method of healing a wound including contacting a wound edge with a tropoelastin or elastin derived peptide in conditions for enabling a sustained contact of the tropoelastin with the wound edge for a time period for enabling re-epithelialization of the wound.

Description

FIELD OF THE INVENTION[0001]The invention relates to wound healing, in particular to improvements to re-epithelialization of wounds.BACKGROUND OF THE INVENTION[0002]Reference to any prior art in the specification is not, and should not be taken as, an acknowledgment or any form of suggestion that this prior art forms part of the common general knowledge in Australia or any other jurisdiction or that this prior art could reasonably be expected to be ascertained, understood and regarded as relevant by a person skilled in the art.[0003]Skin is composed of two layers, the epidermis and the dermis, the latter being connected to the fatty underlying structure, the subcutaneous hypodermis. The epidermis is the thinnest and outermost component of the skin, consisting predominantly of keratinocyte cells. The dermis is a dense connective tissue composed of collagen, elastic fibers, and interfibrillar gel of glycosaminoglycans, salts, and water.[0004]The epidermis and the dermis are interlocke...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/78
CPCA61K38/00C07K14/78A61K38/39A61K9/0014A61L27/56A61K9/06A61K9/70A61L27/22A61L27/3633A61L2400/06A61F13/00063A61F13/0213A61P17/02A61P41/00
Inventor WEISS, ANTHONY STEVEN
Owner APTALIS PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products